|
Volumn 13, Issue 5, 2011, Pages 379-380
|
JAK inhibition in rheumatoid arthritis
|
Author keywords
Antagonist autoimmune; CP 690,550; Efficacy; Inhibition; Interleukin; JAK inhibitor; Methotrexate; Rheumatoid arthritis
|
Indexed keywords
JANUS KINASE 3;
PLACEBO;
TASOCITINIB;
CREATININE BLOOD LEVEL;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
ENZYME INHIBITION;
HUMAN;
INFECTION;
MONOTHERAPY;
MULTICENTER STUDY (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RHEUMATOID ARTHRITIS;
SHORT SURVEY;
SIDE EFFECT;
|
EID: 80755133642
PISSN: 15233774
EISSN: 15346307
Source Type: Journal
DOI: 10.1007/s11926-011-0196-4 Document Type: Short Survey |
Times cited : (2)
|
References (5)
|